| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |